Trials / Unknown
UnknownNCT05850923
The Efficacy of Speech Competition Training on Auditory Hallucination in Schizophrenia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Jing SHI · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
One hundred schizophrenia patients with auditory hallucinations will be recruited and randomized into group A and group B. Participants of group A will firstly receive a speech competition training for 2 weeks, and those in group B will firstly receive music intervention as placebo treatment. Specifically, speech competition training include voice competition training twice a day in adjunction with drug treatment, and the patients will be required to perform voice-related tasks according to the instruction. The reaction time, accuracy rate and the number of auditory hallucinations during the task will be recorded. On the other hand, the placebo treatment includes soothing music twice a day for a fixed period of time while patients receiving drug treatment. After 2 weeks, the interventions for group A and group B will be switch. Clinical symptoms will be evaluated using the auditory hallucinations rating scale, positive and negative syndrome scale, belief about voices questionnaire-revised at baseline, 2-week follow up and 4-week follow up. All the data will be analyzed with the Statistical Product and Service Solutions(SPSS) software.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | speech competition training | Speech competition training include voice competition training twice a day in adjunction with drug treatment, and the patients will be required to perform voice-related tasks according to the instruction. |
| OTHER | the soothing music | the soothing music |
Timeline
- Start date
- 2022-11-15
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2023-05-09
- Last updated
- 2023-07-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05850923. Inclusion in this directory is not an endorsement.